Logo image
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006
Journal article   Open access   Peer reviewed

Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006

Benjamin J Park, Loreen Herwaldt, Peter G Pappas, Kathleen A Wannemuehler, Barbara D Alexander, Elias J Anaissie, David R Andes, John W Baddley, Janice M Brown, Lisa M Brumble, …
Emerging infectious diseases, Vol.17(10), pp.1855-1864
10/2011
DOI: 10.3201/eid1710.110087
PMCID: PMC3311117
PMID: 22000355
url
https://doi.org/10.3201/eid1710.110087View
Published (Version of record) Open Access

Abstract

Recent reports describe increasing incidence of non-Aspergillus mold infections in hematopoietic cell transplant (HCT) and solid organ transplant (SOT) recipients. To investigate the epidemiology of infections with Mucorales, Fusarium spp., and Scedosporium spp. molds, we analyzed data from the Transplant-Associated Infection Surveillance Network, 23 transplant centers that conducted prospective surveillance for invasive fungal infections during 2001-2006. We identified 169 infections (105 Mucorales, 37 Fusarium spp., and 27 Scedosporium spp.) in 169 patients; 124 (73.4%) were in HCT recipients, and 45 (26.6%) were in SOT recipients. The crude 90-day mortality rate was 56.6%. The 12-month mucormycosis cumulative incidence was 0.29% for HCT and 0.07% for SOT. Mucormycosis incidence among HCT recipients varied widely, from 0.08% to 0.69%, with higher incidence in cohorts receiving transplants during 2003 and 2004. Non-Aspergillus mold infections continue to be associated with high mortality rates. The incidence of mucormycosis in HCT recipients increased substantially during the surveillance period.
Mycoses - epidemiology United States - epidemiology Follow-Up Studies Opportunistic Infections - epidemiology Humans Middle Aged Mycoses - microbiology Male Antifungal Agents - therapeutic use Incidence Opportunistic Infections - microbiology Transplantation - adverse effects Opportunistic Infections - drug therapy Mycoses - drug therapy Adult Female Cohort Studies

Details

Metrics

Logo image